Psilocybin Acutely Reduces Low-Frequency BOLD Power and Frequency-Specific Connectivity

Apr 1, 2026·
Anders S. Olsen
,
Kristian Larsen
,
Drummond E.-W. McCulloch
,
Melanie Ganz
,
Martin K. Madsen
,
Brice Ozenne
,
Gitte M. Knudsen
,
Naveed ur Rehman
,
Patrick M. Fisher
· 0 min read
DOI
Abstract
Psilocybin and other serotonergic drugs acutely alter human brain function and large-scale connectivity as measured with BOLD fMRI, but whether these effects are frequency-specific remains unknown. We applied multitaper spectral and cross-spectral analyses to resting-state fMRI data from 28 healthy volunteers scanned multiple times acutely following oral psilocybin administration (0.2 – 0.3 mg/kg), together with plasma psilocin measurements, to estimate psilocin associations with temporal frequency-specific activity and connectivity. Psilocybin produced a selective reduction in low-frequency spectral power (0.01 – 0.06Hz) and an increase in spectral entropy, with the strongest effects in transmodal networks. We also observed a reduction in low-frequency connectivity energy explained by the unimodal/transmodal axis. These findings demonstrate that psilocin induces spatially distributed, frequency-dependent alterations, suggesting that broadband fMRI analyses may obscure low-frequency dynamics. Frequency-resolved approaches may offer greater sensitivity for characterizing psychedelic effects on brain activity.
Type
Publication
bioRxiv
publications